Clinical Trial Update: China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Tongxinluo in acute myocardial infarction, information on status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Tongxinluo

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN